Use of 90Y-ibritumomab tiuxetan in non-Hodgkin's lymphoma

被引：22
|
作者：
Marcus, R [1 ]
机构：
[1] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England
来源：
SEMINARS IN ONCOLOGY | 2005年 / 32卷 / 01期
关键词：
D O I：
10.1053/j.seminoncol.2005.01.012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S36 / S43
页数：8
相关论文
共 50 条
  • [1] RIT WITH 90Y-IBRITUMOMAB TIUXETAN IMPROVES THE RESPONSE IN AGGRESSIVE NON-HODGKIN LYMPHOMA
    Montes Limon, A.
    Andrade Campos, M.
    Murillo Flores, I.
    Grasa Ulrich, J. M.
    Lievano, P.
    Baringo, T.
    Giraldo Castellanos, P.
    HAEMATOLOGICA, 2012, 97 : 667 - 668
  • [2] 90Y-ibritumomab tiuxetan:: Rationale for patient selection in the treatment of indolent non-Hodgkin's lymphoma
    Grillo-López, AJ
    SEMINARS IN ONCOLOGY, 2005, 32 (01) : S44 - S49
  • [3] 90Y-ibritumomab tiuxetan therapy of follicular non-Hodgkin's lymphoma: the experience in our hospital
    Ramal Leiva, D.
    Sabate-Llobera, A.
    Mercadal Vilchez, S.
    Garcia Munoz, N.
    Roca Engronyat, M.
    Mora Salvado, J.
    Martin-Comin, J.
    Gonzalez-Barca, E.
    Ricart Brulles, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S429 - S429
  • [4] SINGLE CENTER EXPERIENCE OF 90Y-IBRITUMOMAB TIUXETAN IN THE OLDER POPULATION WITH NON-HODGKIN LYMPHOMA
    Agrawal, V.
    Castillo, J.
    Raup, K.
    Girton, T.
    Collins, S.
    Brady, J.
    Vadakara, J.
    Khan, S.
    HAEMATOLOGICA, 2016, 101 : 481 - 482
  • [5] Diagnostic imaging prior to 90Y-ibritumomab tiuxetan (Zevalin®) treatment in follicular non-Hodgkin's lymphoma
    Otte, Andreas
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2008, 11 (01): : 12 - 15
  • [6] Single center experience of 90Y-Ibritumomab tiuxetan in the older population with non-hodgkin lymphoma.
    Agrawal, Vaibhav
    Castillo, Jose Isaac
    Raup, Kelly
    Girton, Treanna
    Collins, Scott R.
    Brady, James O.
    Khan, Sharif S.
    Vadakara, Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] RADIOIMMUNOTHERAPY CASES REGISTRY: RECURRENT OR REFRACTORY NON-HODGKIN LYMPHOMA TREATED WITH 90Y-IBRITUMOMAB TIUXETAN
    Gomez-Codina, J.
    Giraldo, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 232 - 232
  • [8] Experience with 90Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma
    Younes, A.
    Wong, F.
    ANNALS OF ONCOLOGY, 2009, 20 (06) : 1147 - 1148
  • [9] Therapeutic efficacy and toxicity of 90Y-Ibritumomab tiuxetan in patients with B-Cell non-Hodgkin's lymphoma
    Boni, G.
    Lorenzoni, A.
    Galimberti, S.
    Cecconi, N.
    Genovesi, D.
    Grosso, M.
    Ciuti, S.
    Petrini, M.
    Mariani, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S169 - S169
  • [10] Ibritumomab tiuxetan for non-Hodgkin's lymphoma
    Johnston, Patrick B.
    Bondly, Cara
    Micallef, Ivana N. M.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (06) : 861 - 869
12345